Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48:526–535.
Castano-Milla C, Chaparro M, Gisbert JP. Systematic review with meta-analysis: the declining risk of colorectal cancer in Ulcerative colitis. Aliment Pharmacol Ther 2014;39:645–659.
Eaden JA, Mayberry JF. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 2002;51 (Suppl 5): V10–V12.
Mowat C, Cole A, Windsor A et al. Guidelines for the management of inflammatory bowel disease in adults. Gut 2011;60:571–607.
Van Assche G, Dignass A, Bokemeyer B et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 2013;7:1–33.
Laine L, Kaltenbach T, Barkun A et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology 2015;148:639–651.
Fort Gasia M, Ghosh S, Panaccione R et al. Targeted biopsies identify larger proportions of patients with colonic neoplasia undergoing high-definition colonoscopy, dye chromoendoscopy, or electronic virtual chromoendoscopy. Clin Gastroenterol Hepatol 2016;14:704–712.
Kiesslich R, Fritsch J, Holtmann M et al. Methylene blue aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003;124:880–888.
Marion JF, Waye JD, Present DH et al. Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol 2008;103:2342–2349.
Rutter MD, Saunders BP, Wilkinson KH et al. Most dysplasia in ulcerative colitis is visible at colonoscopy. Gastrointest Endosc 2004;6:334–339.
Marion JF, Waye JD, Israel Y et al. Chromoendoscopy is more effective than standard colonoscopy in detecting dysplasia during long-term surveillance of patients with colitis. Clin Gastroenterol Hepatol 2016;14:713–719.
Mooiweer E, Van der Meulen-de Jong AE, Ponsioen CY et al. Chromoendoscopy for surveillance in inflammatory bowel dis- ease does not increase neoplasia detection compared with conventional colonoscopy with random biopsies: results from a large retrospective study. Am J Gastroenterol 2015;110:1014–10.
Dekker E, Van den Broek FJ, Reitsma JB et al. Narrowband imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis. Endoscopy 2007;39:216–221.
Ignjatovic A, East JE, Subramanian V et al. Narrow band imaging for detection of dysplasia in colitis: a randomized controlled trial. Am J Gastroenterol 2012;107:885–890.
Van den Broek FJC, Fockens P, Van ES et al. Narrowband imaging versus high-definition endoscopy for the diagnosis of neoplasia in ulcerative colitis. Endoscopy 2011;43:108–115.
Iacucci M, Panaccione R, Ghosh S. Advances in novel diagnostic endo-scopic imaging techniques in inflammatory bowel disease. Inflamm Bowel Dis 2013;19:873–880.
Kodashima S, Fujishiro M. Novel image-enhanced endoscopy with iscan technology. World J Gastroenterol 2010;16:1043–1049.
Atkinson M, Chak A. I-Scan: chromoendoscopy without the hassle? Dig Liver Dis 2010;42:18–19.
Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. New Engl J Med 1987;317:1625–1629.
Best WR, Becktel JM, Singleton JW. Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI). Gastroenterology 1979;77 (4 Pt2): 843–846.
Rostom A, Jolicoeur E. Validation of a new scale for the assessment of bowel preparation quality. Gastrointest Endosc 2004;59:482–486.
Daperno M, D'Haens G, Van Assche G et al. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD. Gastrointest Endosc 2004;60:505–512.
The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc 2003;58:S3–43.
Kudo S, Rubio CA, Teixeira CR et al. Pit pattern in colorectal neoplasia: endoscopic magnifying view. Endoscopy 2001;33 (4): 367–373.
Hefti MM, Chessin DB, Harpaz NH et al. Severity of inflammation as a predictor of colectomy in patients with chronic ulcerative colitis. Dis Colon Rectum 2009;52:193–197.
Schlemper RJ, Riddell RH, Kato Y et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000;47:251–255.
Subramanian V, Ramappa V, Telakis E et al. Comparison of high definition with standard white light endoscopy for detection of dysplastic lesions during surveillance colonoscopy in patients with colonic inflammatory bowel disease. Inflamm Bowel Dis 2013;19:350–355.
Carballal S, Maisterra S, López-Serrano A et al. Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD. Gut 2016 [Epub ahead of print].
Ananthakrishnan AN. Chromoendoscopy is better: so why am i not (yet) using it for routine inflammatory bowel disease surveillance? Clin Gastroenterol Hepatol 2016;14:720–722.
Hove JT, Mooiweer E, Van Der Meulen A et al. Biopsies taken from mucosa surrounding dysplastic lesions found during ibd surveillance show a low rate of dysplasia. Gastrointest Endosc 2016;83 (5): abstract 153.
Van Assche G, Dignass A, Bokemeyer B. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 2013;7:1–33.
Kamiński MF, Hassan C, Bisschops R et al. Advanced imaging for detection and differentiation of colorectal neoplasia: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2014;46:435–449.
Pellisé M, López-Cerón M, Rodríguez de Miguel C et al. Narrow-band imaging as an alternative to chromoendoscopy for the detection of dysplasia in long-standing inflammatory bowel disease: a prospective, randomized, crossover study. Gastrointest Endosc 2011;74:840–848.
Sonwalkar S, Rotimi O, Rembacken BJ et al. Characterization of colonic polyps at conventional (nonmagnifying) colonoscopy after spraying with 0.2% indigo carmine dye. Endoscopy 2006;38:1218–1223.
Soetikno R, Subramanian V, Kaltenbach T et al. The detection of nonpolypoid (flat and depressed) colorectal neoplasms in patients with inflammatory bowel disease. Gastroenterology 2013;144:1349–1352.
Barreiro-de Acosta M, Vallejo N, de la Iglesia D et al. Evaluation of the risk of relapse in ulcerative colitis according to the degree of mucosal healing (mayo 0 vs 1): a longitudinal cohort study. J Crohn’s Colitis 2016;10:13–19.
Rutter MD, Saunders BP, Schofield G et al. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 2004;53:256–260.